Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

PURPOSE: The Tamoxifen and Exemestane Trial (TEXT)/Suppression of Ovarian Function Trial (SOFT) showed superior outcomes for premenopausal women with hormone receptor (HR)–positive breast cancer treated with adjuvant exemestane plus ovarian function suppression (OFS) or tamoxifen plus OFS versus tam...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagani, Olivia, Francis, Prudence A., Fleming, Gini F., Walley, Barbara A., Viale, Giuseppe, Colleoni, Marco, Láng, István, Gómez, Henry L., Tondini, Carlo, Pinotti, Graziella, Di Leo, Angelo, Coates, Alan S., Goldhirsch, Aron, Gelber, Richard D., Regan, Meredith M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164485/
https://www.ncbi.nlm.nih.gov/pubmed/31618131
http://dx.doi.org/10.1200/JCO.18.01967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164485/
https://www.ncbi.nlm.nih.gov/pubmed/31618131
http://dx.doi.org/10.1200/JCO.18.01967

Ejemplares similares